Plasma Based Markers of [11C] PiB-PET Brain Amyloid Burden

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kiddle, Steven John ^a,b   Thambisetty, Madhav ^c   Simmons, Andrew ^a,b   Riddoch Contreras, Joanna ^b   Hye, Abdul ^b   Westman, Eric ^a,b   Pike, Ian ^d   Ward, Malcolm ^d   Johnston, Caroline ^a,b   Lupton, Michelle Katharine ^b   Lunnon, Katie ^b   Soininen, Hilkka ^e   Kloszewska, Iwona ^f   Tsolaki, Magda ^g   Vellas, Bruno ^h   Mecocci, Patrizia ⁱ   Lovestone, Simon ^a,b   Newhouse, Stephen ^a,b   Dobson, Richard ^a,b  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d Proteome Sciences plc   (United Kingdom)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^h TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMYLOID; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; C PEPTIDE; COMPLEMENT COMPONENT C3; FIBRINOGEN; GELATINASE B; HYDROCORTISONE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 3; PANCREAS POLYPEPTIDE; PITTSBURGH COMPOUND B; PROTEIN KINASE AXL; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VITRONECTIN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; GENE SEQUENCE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; BRAIN; CLUSTER ANALYSIS; FEMALE; GENOTYPE; HUMANS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REPRODUCIBILITY OF RESULTS; THIAZOLES;

EID: 84866665307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044260     Document Type: Article

References (53)

1. Golde TE, Schneider LS, Koo EH, (2008) Anti-Aβ therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron 69: 203-213.
2. Reiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, et al. (2011) Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis 26: 321-329.
3. Aisen PS, Andrieu S, Sampaio C, Carrillo M, Khachaturian ZS, et al. (2011) Report of the task force on designing clinical trials in early (predementia) AD. Neurology 76: 280-286.
4. Grimmer T, Riemenschneider M, Förstl H, Henriksen G, Klunk WE, et al. (2009) Beta amyloid in Alzheimer's disease: increased deposition in brain is reected in reduced concentration in cerebrospinal fluid. Biol Psychiatry 65: 927-934.
5. Koivunen J, Pirttilä T, Kemppainen N, Aalto S, Herukka SK, et al. (2008) PET amyloid ligand [11C] PIB uptake and cerebrospinal uid beta-amyloid in mild cognitive impairment. Dement Geriatr Cogn Disord 26: 378-383.
6. Zhang R, Barker L, Pinchev D, Marshall J, Rasamoelisolo M, et al. (2004) Mining biomarkers in human sera using proteomic tools. Proteomics 4: 244-256.
7. Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, et al. (2006) Proteome-based plasma biomarkers for Alzheimer's disease. Brain 129: 3042-3050.
8. Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW,et al. (Ahead of print) Plasma biomarkers associated with the apolipoprotein e genotype and alzheimer disease. Arch Neurol.
9. Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC,et al. (Ahead of print) Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol.
10. Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, et al. (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67: 739-748.
11. Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, et al. (2011) Plasma biomarkers of brain atrophy in Alzheimer's disease. PloS one 6: e28527.
12. Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, et al. (2012) Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage 59: 212-217.
13. Thambisetty M, Hye A, Foy C, Daly E, Glover A, et al. (2008) Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease. J Neurol 255: 1712-1720.
14. Thambisetty M, Tripaldi R, Riddoch-Contreras J, Hye A, An Y, et al. (2010) Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. J Alzheimers Dis 22: 1099-1109.
15. Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, et al. (2011) Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology 76: 1091-1098.
16. Jagust WJ, Bandy D, Chen K, Foster NL, Landau SM, et al. (2010) The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement 6: 221-229.
17. Slooter AJ, de Knijff P, Hofman A, Cruts M, Breteler MM, et al. (1998) Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study. Neurosci Lett 248: 21-24.
18. Siest G, Bertrand P, Qin B, Herbeth B, Serot JM, et al. (2000) Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. Clin Chem Lab Med 38: 721-730.
19. Evans AE, Zhang W, Moreel JF, Bard JM, Ricard S, et al. (1993) Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men. Hum Genet 92: 191-197.
20. Johnstone D, Milward EA, Berretta R, Moscato P, (2012) ADNI (2012) Multivariate protein signatures of pre-clinical Alzheimers disease in the Alzheimers Disease Neuroimaging Initiative (ADNI) plasma proteome dataset. PLoS one 7: e34341.
21. Ewers M, Insel P, Jagust WJ, Shaw L, Trojanowski JQ, et al. (2012) CSF Biomarker and PIBPET-Derived Beta-Amyloid Signature Predicts Metabolic, Gray Matter, and Cognitive Changes in Nondemented Subjects. Cerebral Cortex 22: 1993-2004.
22. Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, et al. (2012) Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimers Disease Blood. J Alz Dis 30: 685-710.
23. Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, et al. (2008) Complement C3 deficiency leads to accelerated amyloid β plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci 28: 6333-6341.
24. Wetterling T, Tegtmeyer KF, (1994) Serum alpha 1-antitrypsin and alpha 2-macroglobulin in Alzheimer's and Binswanger's disease. Clin Investig 72: 196-199.
25. Bemelmans KJ, Noort A, Rijk RD, Middelkoop HAM, Kempen GMJV, et al. (2007) Plasma cortisol and norepinephrine in Alzheimer's disease: opposite relations with recall performance and stage of progression. Acta Neuropsychiatr 19: 231-237.
26. Lee BK, Glass TA, Wand GS, McAtee MJ, Bandeen-Roche K, et al. (2008) Apolipoprotein E genotype, cortisol, and cognitive function in community-dwelling older adults. Am J Psychiat 165: 1456-1464.
27. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, et al. (2007) Classification and prediction of clinical Alzheimers diagnosis based on plasma signaling proteins. Nat Med 13: 1359-1362.
28. Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, et al. (2003) Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int 43: 191-196.
29. O'Bryant SE, Xiao G, Barber R, Huebinger R, Wilhelmsen K, et al. (2011) A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI. PLoS one 6: e28092.
30. Nishiyama E, Iwamoto N, Kimura M, Arai H, (1996) Serum amyloid P component level in Alzheimer's disease. Dementia 7: 256-259.
31. OBryant SE, Xiao G, Barber R, Reisch J, Doody R, et al. (2010) A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol 67: 1077-1081.
32. Mold M, Shrive A, (2012) Serum amyloid P component accelerates the formation and enhances the stability of amyloid fibrils in a physiologically significant under-saturated solution of amyloid-Aβ42. J Alzheimers Dis 29: 875-881.
33. de la Monte SM, Wands JR, (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. J Alzheimers Dis 7: 45-61.
34. Zambrano A, Otth C, Mujica L, Concha II, Maccioni RB, (2007) Interleukin-3 prevents neuronal death induced by amyloid peptide. BMC Neurosci 8: 82.
35. Greco SJ, Sarkar S, Johnston JM, Tezapsidis N, (2009) Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem Bioph Res Co 380: 98-104.
36. Szczepanik AM, Funes S, Petko W, Ringheim GE, (2001) IL-4, IL-10 and IL-13 modulate Aβ(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113: 49-62.
37. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, et al. (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 485: 512-516.
38. Kohavi R, (1995) A study of cross-validation and bootstrap for accuracy estimation and model selection. Proceedings of IJCAI'95 2: 1137-1143.
39. Alzheimers Association, (2004) Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators. Alzheimer Dis Assoc Disord 18: 171-175.
40. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, et al. (2009) MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology 73: 287-297.
41. Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, et al. (2010) Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement 6: 230-238.
42. Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ, Koeppe RA, et al. (2009) Relationships between biomarkers in aging and dementia. Neurology 73: 1193.
43. R Development Core Team (2011) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org. ISBN 3-900051-07-0.
44. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, et al. (2009) MRI measures of Alzheimers disease and the AddNeuroMed study. Ann NY Acad Sci 1180: 47-55.
45. Simmons A, Westman E, Muehlboeck S, Mecocci P, Vellas B, et al. (2011) The AddNeuroMed framework for multi-centre MRI assessment of longitudinal changes in Alzheimers disease: experience from the first 24 months. Int J Ger Psych 26: 75-82.
46. Westman E, Muehlboeck JS, Simmons A, (2012) Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage 62: 229-238.
47. Westman E, Aguilar C, Muehlboeck JS, Simmons A (In press) Regional magnetic resonance imaging measures for multivariate analysis in Alzheimers disease and mild cognitive impairment. Brain Topogr DOI: 10.1007/s10548-012-0246-x.
48. Kim S (2011) ppcor: Partial and Semi-partial (Part) correlation. The Comprehensive R Archive Network website. URL http://CRAN.R-project.org/package=ppcor. Accessed 2012 August 17. R package version 0.9-38.
49. Warnes GR, Bolker B, Bonebakker L, Gentleman R, Huber W, et al. (2011) gplots: Various R programming tools for plotting data. The Comprehensive R Archive Network website. URL http://CRAN.R-project.org/package=gplots. Accessed 2012 August 17. R package version 0.9-38.
50. Stevenson M, Nunes T, Sanchez J, Thornton R, Reiczigel J, et al. (2012) epiR: An R package for the analysis of epidemiological data. The Comprehensive R Archive Network website. URL http://CRAN.R-project.org/package=epiR. Accessed 2012 August 17. R package version 0.9-38.
51. Lindeman RH, Merenda PF, Gold RZ (1980) Introduction to Bivariate and Multivariate Analysis. Scott Foreman, Glenview, IL, 120-127.
52. Grömping U, (2006) Relative importance for linear regression in R: the package relaimpo. J Stat Softw 17: 1-27.
53. Lovestone S, Francis P, Kloszewska I, Meccoci P, Simmons A, et al. (2009) AddNeuroMed - the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann NY Acad Sci 1180: 36-46.